English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
Apr 18, 2023 11:00 HKT
Endurance RP: Excellent Positive Results from Phase 3 Randomised Clinical Trial of Fortacin(TM)/Senstend(TM) in China
Apr 17, 2023 22:29 HKT
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Apr 17, 2023 19:30 HKT
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore
Apr 14, 2023 17:18 HKT
Responding to the Need for Accelerated Nursing Credentials Verification, CGFNS and NCSBN Step Up Collaboration to Address Gaps and Improve Efficiencies
Apr 12, 2023 19:30 HKT
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China
Apr 11, 2023 12:58 HKT
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50%
Apr 11, 2023 08:00 HKT
Life Science Incubator Signs MOU with a strategic anchor tenant for its planned Brisbane Co-Working Laboratory Space Project
Apr 06, 2023 14:00 HKT
Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product
Apr 05, 2023 18:00 HKT
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Apr 04, 2023 17:00 HKT
Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022
Apr 03, 2023 14:52 HKT
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition
Apr 03, 2023 12:00 HKT
Sino Biopharm (1177.HK) Announces 2022 Annual Results
Mar 31, 2023 21:11 HKT
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 20:15 HKT
Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia
Mar 31, 2023 09:28 HKT
Ocumension Therapeutics Announces 2022 Annual Results
Mar 30, 2023 22:29 HKT
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
Mar 30, 2023 20:29 HKT
Universal Medical (2666.HK) Announces 2022 Annual Results
Mar 29, 2023 19:35 HKT
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter
Mar 28, 2023 20:00 HKT
Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
Mar 28, 2023 19:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: